NEXGEL, INC. Finance Lease, Right-of-Use Asset, Amortization
NEXGEL, INC. (NXGL) reported Finance Lease, Right-of-Use Asset, Amortization of $73.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-05-14
- NEXGEL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $73.00K, a 25.86% increase year-over-year.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $58.00K, a 728.57% increase year-over-year.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2024-03-31 was $7.00K, a 85.71% decline year-over-year.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2023-03-31 was $49.00K.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $290.00K, a 27.75% increase from fiscal 2024.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $227.00K, a 4.61% increase from fiscal 2023.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $217.00K, a 14.81% increase from fiscal 2022.
- NEXGEL, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $189.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|
| 2026-03-31 | $73.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $290.00K 10-K · filed 2026-03-31 | |||
| 2025-03-31 | $58.00K 10-Q · filed 2026-05-14 | $12.00K 10-Q · filed 2025-05-13 | ||
| 2024-12-31 | $227.00K 10-K · filed 2026-03-31 | $42.00K 10-K · filed 2025-03-27 | ||
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-13 | $52.00K 10-Q · filed 2024-05-13 | ||
| 2023-12-31 | $217.00K 10-K · filed 2025-03-27 | |||
| 2023-03-31 | $49.00K 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $189.00K 10-K · filed 2024-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |